Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real-world efficacy.
A University at Buffalo researcher who studies adolescent HIV prevention in African and diaspora communities was invited to contribute a commentary in the April issue of The Lancet Child & Adolescent ...
For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...
The West and Central African region has made notable progress in the AIDS response in recent years. UNAIDS data show that in 2024, 81% of people living with HIV knew their status, 76% were accessing ...
When left untreated, H.I.V. infection is relentless. Because it destroys the immune system, the virus makes people vulnerable ...
People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results